CPB2 and inflammatory breast carcinoma: IL-10 stimulates the expression of carboxypeptidase B2 and promotes lymphovascular invasion in inflammatory breast cancer cell-line SUM-149, but not in non-inflammatory breast cancer cell MDA-MB-231 [19].